PRINCETON CAPITAL MANAGEMENT LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRINCETON CAPITAL MANAGEMENT LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$887,671
-7.5%
22,153
-5.7%
0.37%
-10.2%
Q1 2023$959,157
+2.3%
23,503
-3.2%
0.41%
-1.4%
Q4 2022$937,296
-30.8%
24,276
-4.6%
0.42%
-29.7%
Q3 2022$1,354,000
-5.4%
25,450
+3.7%
0.59%
+6.8%
Q2 2022$1,431,000
-24.7%
24,539
-1.5%
0.56%
-6.1%
Q1 2022$1,901,000
+25.1%
24,906
-1.3%
0.59%
+35.6%
Q4 2021$1,519,000
+11.5%
25,241
+3.8%
0.44%
+0.5%
Q3 2021$1,362,000
-3.9%
24,324
+4.2%
0.43%
-0.9%
Q2 2021$1,417,000
-10.2%
23,345
+3.7%
0.44%
-18.0%
Q1 2021$1,578,000
+19.1%
22,511
+1.6%
0.53%
+12.7%
Q4 2020$1,325,000
+1.8%
22,149
+2.3%
0.47%
-9.5%
Q3 2020$1,302,000
+19.6%
21,649
+4.3%
0.52%
+8.5%
Q2 2020$1,089,000
+64.3%
20,748
+30.6%
0.48%
+40.0%
Q1 2020$663,000
-28.8%
15,886
-19.3%
0.34%
-17.1%
Q4 2019$931,000
+17.0%
19,680
-5.8%
0.42%
+7.5%
Q3 2019$796,000
-12.5%
20,899
-0.1%
0.39%
-12.8%
Q2 2019$910,000
+20.5%
20,928
+5.5%
0.44%
+16.5%
Q1 2019$755,000
-17.9%
19,829
-7.2%
0.38%
-29.1%
Q4 2018$920,000
-32.6%
21,378
-23.0%
0.54%
-5.1%
Q3 2018$1,365,000
+50.3%
27,768
-2.0%
0.57%
+43.3%
Q2 2018$908,000
+2.1%
28,339
-0.7%
0.40%0.0%
Q1 2018$889,000
-33.0%
28,549
-1.7%
0.40%
-33.4%
Q4 2017$1,326,00029,0380.59%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Key Colony Management, LLC 134,600$13,045,00011.31%
Biondo Investment Advisors, LLC 279,717$27,110,0008.33%
GILDER GAGNON HOWE & CO LLC 3,177,130$307,927,0004.48%
DARUMA CAPITAL MANAGEMENT LLC 814,470$78,938,0003.47%
MAGEE THOMSON INVESTMENT PARTNERS LLC 126,022$12,214,0003.01%
NEXT CENTURY GROWTH INVESTORS LLC 768,396$74,472,0002.63%
MARXE AUSTIN W & GREENHOUSE DAVID M 180,000$17,446,0002.38%
Lisanti Capital Growth, LLC 48,280$4,679,0002.35%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 79,017$7,658,0002.00%
Atika Capital Management LLC 21,500$2,084,0001.60%
View complete list of PACIRA PHARMACEUTICALS INC shareholders